Neuropathy: Clinical Trials

9 trials for Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 not yet recruiting, 1 unknown. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 4, Terminated 2, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Neuropathy: new trials by email Literature Review of Neuropathy trials Research Report on Neuropathy

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Glutamine (Pharmacological doses) - Neuropathy, Cancer
Phase 3Not yet recruitingAin Shams University702025-12-302025-12-17
Vit D3 and Omega 3 in Chemo Induced Neuropathy
mammalian Omega 3 Fatty acids, placebo - Cancer, Neuropathy
Phase 3UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre6002015-01-012015-04-07
Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet
Polyamines depleted diet, associating Polydol® cans and predefined menus low in polyamines - Neuropathy, Digestive Cancer System
Phase 3CompletedUniversity Hospital, Clermont-Ferrand802013-02-022017-07-11
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Acetyl-L-Carnitine Hydrochloride, Placebo, Questionnaire Administration - Fatigue, Malignant Ovarian Mixed Epithelial Tumor
Phase 3WithdrawnGynecologic Oncology Group2012-04-012014-12-31
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
calcium gluconate, magnesium sulfate, placebo - Chemotherapeutic Agent Toxicity, Colorectal Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology3622010-06-012022-11-03
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
pregabalin, placebo - Neuropathy
Phase 3TerminatedPfizer's Upjohn has merged with Mylan to form Viatris Inc.3772010-04-012021-01-28
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Carboplatin, Glutathione, Laboratory Biomarker Analysis - Chemotherapeutic Agent Toxicity, Neuropathy
Phase 3CompletedAlliance for Clinical Trials in Oncology1952009-12-012017-02-23
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
Calcium Gluconate, Magnesium Sulfate, Placebo - Neuropathy, Pain
Phase 3TerminatedMayo Clinic12009-11-012016-02-04
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
acetyl-L-carnitine hydrochloride, placebo - Breast Cancer, Chemotherapeutic Agent Toxicity
Phase 3CompletedSWOG Cancer Research Network4372009-09-012017-08-14

Narrower conditions

Neurotoxicity Syndromes (4)  ·  Pain (4)  ·  Breast Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Fatigue (2)  ·  Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Brenner Tumor (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Neoplasms (1)  ·  HIV Infections (1)  ·  Hyperalgesia (1)  ·  Paresthesia (1)  ·  Rectal Neoplasms (1)

Broader conditions

Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Chemically-Induced Disorders (4)  ·  Poisoning (4)  ·  Genital Diseases (3)  ·  Urogenital Diseases (3)  ·  Adnexal Diseases (2)  ·  Breast Diseases (2)  ·  Digestive System Diseases (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)

Interventions

Calcium Gluconate (2)  ·  Magnesium Sulfate (2)  ·  Calcium (1)  ·  Carboplatin (1)  ·  Glutamine (1)  ·  Glutathione (1)  ·  Oxaliplatin (1)  ·  Paclitaxel (1)  ·  Polyamines (1)  ·  Pregabalin (1)  ·  Taxes (1)  ·  ixabepilone (1)

Sponsors

Alliance for Clinical Trials in Oncology (2)  ·  Ain Shams University (1)  ·  Gynecologic Oncology Group (1)  ·  Mayo Clinic (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)  ·  SWOG Cancer Research Network (1)  ·  University Hospital, Clermont-Ferrand (1)

Countries

United States (5)  ·  Puerto Rico (2)  ·  Canada (1)  ·  Colombia (1)  ·  Dominican Republic (1)  ·  Egypt (1)  ·  France (1)  ·  India (1)  ·  Peru (1)  ·  Poland (1)  ·  South Africa (1)  ·  Thailand (1)

Top investigators

Charles Loprinzi (2)  ·  Charles L. Loprinzi, MD (1)  ·  David Kushner (1)  ·  Laurence H. Baker, DO, FACOI (1)

Results publications

PMID 23733756, PMID 24297951, PMID 24907403, PMID 25833669, PMID 34176021

NIH funding

P30CA015083 (1), U10CA037404 (1), U10CA037429 (1), U10CA101165 (1)